Compounds > ly 353381
Page last updated: 2024-09-05

ly 353381 and odanacatib

ly 353381 has been researched along with odanacatib in 1 studies

Compound Research Comparison

Studies
(ly 353381)		Trials
(ly 353381)		Recent Studies (post-2010)
(ly 353381)		Studies
(odanacatib)		Trials
(odanacatib)		Recent Studies (post-2010) (odanacatib)
70121514827128

Protein Interaction Comparison

ProteinTaxonomyly 353381 (IC50)odanacatib (IC50)
Cathepsin L2Homo sapiens (human)0.762
Procathepsin LHomo sapiens (human)3.919
Cathepsin BHomo sapiens (human)1.3613
Cathepsin SHomo sapiens (human)0.197
Cathepsin KHomo sapiens (human)0.0005
Cathepsin KOryctolagus cuniculus (rabbit)0.001
Cathepsin FHomo sapiens (human)0.795

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Villiers, TJ1

Reviews

1 review(s) available for ly 353381 and odanacatib

ArticleYear
The quest for new drugs to prevent osteoporosis-related fractures.
    Climacteric : the journal of the International Menopause Society, 2017, Volume: 20, Issue:2

    Topics: Benzoates; Biphenyl Compounds; Bone Density Conservation Agents; Drug Discovery; Humans; Osteoporosis; Osteoporotic Fractures; Piperidines; Propanolamines; Pyrrolidines; Tetrahydronaphthalenes; Thiophenes

2017